X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (177) 177
Newspaper Article (93) 93
Publication (58) 58
Book / eBook (21) 21
Dissertation (9) 9
Newsletter (8) 8
Magazine Article (2) 2
Conference Proceeding (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (126) 126
index medicus (117) 117
female (100) 100
male (81) 81
middle aged (53) 53
adult (50) 50
aged (39) 39
article (36) 36
analysis (34) 34
athletes (34) 34
abridged index medicus (30) 30
adolescent (30) 30
child (30) 30
research (30) 30
public health (29) 29
child, preschool (28) 28
health aspects (28) 28
professional baseball (28) 28
public, environmental & occupational health (27) 27
children (26) 26
studies (26) 26
young adult (26) 26
infant (25) 25
united states (24) 24
risk factors (23) 23
pediatrics (22) 22
mortality (21) 21
risk (19) 19
care and treatment (17) 17
dentistry (17) 17
epidemiology (17) 17
internal medicine (17) 17
medical research (17) 17
infant, newborn (16) 16
cancer (15) 15
diagnosis (15) 15
medical colleges (15) 15
medicine, general & internal (15) 15
patients (15) 15
prevalence (15) 15
usage (15) 15
medicine (14) 14
medicine & public health (14) 14
oncology (14) 14
treatment outcome (14) 14
care (13) 13
cross-sectional studies (13) 13
health (13) 13
surgery (13) 13
united-states (13) 13
aged, 80 and over (12) 12
children & youth (12) 12
clinical trials (12) 12
hospitals (12) 12
pregnancy (12) 12
prevention (12) 12
united states - epidemiology (12) 12
women (12) 12
womens health (12) 12
automobile racing (11) 11
breast cancer (11) 11
colleges & universities (11) 11
contracts (11) 11
dental care (11) 11
management (11) 11
north carolina (11) 11
age factors (10) 10
diabetes (10) 10
follow-up studies (10) 10
infants (10) 10
medicine, experimental (10) 10
obesity (10) 10
oral health (10) 10
professional hockey (10) 10
surveys and questionnaires (10) 10
adults (9) 9
case-control studies (9) 9
education (9) 9
exercise (9) 9
parents (9) 9
regression analysis (9) 9
respiratory system (9) 9
cohort studies (8) 8
college basketball (8) 8
dentistry, oral surgery & medicine (8) 8
disease (8) 8
gastroenterology & hepatology (8) 8
health knowledge, attitudes, practice (8) 8
medicaid (8) 8
metaanalysis (8) 8
prospective studies (8) 8
risk-factors (8) 8
socioeconomic factors (8) 8
time factors (8) 8
traffic accidents & safety (8) 8
trends (8) 8
age (7) 7
asthma (7) 7
brain (7) 7
emergency medicine (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
UTL at Downsview - May be requested (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Reference (1) 1
Gerstein Science - Stacks (1) 1
New College (Ivey) - Withdrawn (1) 1
OISE - Curriculum Resources (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 10008, pp. 2078 - 2088
Summary Background Despite preventive vaccines for oncogenic human papillomaviruses (HPVs), cervical intraepithelial neoplasia (CIN) is common, and current... 
Internal Medicine | REGRESSION | MEDICINE, GENERAL & INTERNAL | ELECTROPORATION | METHYLATION | INTEGRATION | IMMUNOTHERAPY | E2 BINDING-SITES | NATURAL-HISTORY | CANCER | BURDEN | EXPRESSION | Human papillomavirus 18 - immunology | Humans | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Cervical Intraepithelial Neoplasia - drug therapy | Human papillomavirus 16 - immunology | Papillomavirus E7 Proteins - genetics | Young Adult | Cancer Vaccines - therapeutic use | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | DNA-Binding Proteins - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Repressor Proteins - genetics | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Vaccines, DNA - therapeutic use | DNA-Binding Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Repressor Proteins - immunology | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Proteins | Cervix dysplasia | DNA | Clinical trials | Product development | Vaccines | Health aspects | Papillomavirus infections | Medical research | Analysis | Medicine, Experimental | Human papillomavirus | Immunization | Womens health | Immunotherapy | Genomes | Cervical cancer | Deoxyribonucleic acid--DNA
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2012, Volume 76, Issue 1, pp. 126 - 135
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2009, Volume 53, Issue 5, pp. 823 - 834
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10087, pp. 2375 - 2382
Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require... 
Internal Medicine | RHEUMATOID-ARTHRITIS | CYCLO-OXYGENASE-2 | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY | DICLOFENAC | PREVENTION | RISK | OSTEOARTHRITIS | Celecoxib - administration & dosage | Recurrence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Secondary Prevention - methods | Aspirin - administration & dosage | Cyclooxygenase 2 Inhibitors - adverse effects | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Aspirin - therapeutic use | Drug Therapy, Combination | Celecoxib - adverse effects | Naproxen - adverse effects | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Cyclooxygenase 2 Inhibitors - administration & dosage | Peptic Ulcer Hemorrhage - chemically induced | Celecoxib - therapeutic use | Proton Pump Inhibitors - therapeutic use | Naproxen - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Aged | Care and treatment | Aspirin | Anti-inflammatory drugs | Gastrointestinal diseases | Naproxen | Clinical trials | Arthritis | Complications and side effects | Medical research | Gastrointestinal bleeding | Medicine, Experimental | Drugs | Funding | Risk | Population studies | Hemorrhage | Bleeding | Incidence | Prostaglandin endoperoxide synthase | Motivation | Safety | Nonsteroidal anti-inflammatory drugs | Antiinflammatory agents | Digestive system | Risk reduction | Inflammation | Celecoxib | Patients | Diseases | Omeprazole | Random numbers | Inhibitors | Ulcers | Healing | Fatalities | Cyclooxygenase-2 | Cardiovascular diseases | Health risk assessment
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9573, pp. 1621 - 1626
Summary Background Guidelines on pain management recommend that patients at risk of ulcers receive either a cyclo-oxygenase (COX 2) inhibitor or a... 
Internal Medicine | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | NSAID | CYCLOOXYGENASE-2 INHIBITORS | ARTHRITIS PATIENTS | NAPROXEN | COMPLICATIONS | HELICOBACTER-PYLORI | PEPTIC-ULCER | CELECOXIB | Pyrazoles - therapeutic use | Humans | Esomeprazole - adverse effects | Male | Secondary Prevention | Osteoarthritis - drug therapy | Esomeprazole - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Female | Drug Therapy, Combination | Pyrazoles - adverse effects | Anti-Ulcer Agents - therapeutic use | Double-Blind Method | Proton Pump Inhibitors | Risk Factors | Anti-Ulcer Agents - adverse effects | Peptic Ulcer Hemorrhage - chemically induced | Treatment Outcome | Celecoxib | Peptic Ulcer Hemorrhage - therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Sulfonamides - adverse effects | Aged | Cyclooxygenase Inhibitors - adverse effects | Cyclooxygenase Inhibitors - therapeutic use | Prevention | Complications and side effects | COX-2 inhibitors | Relapse | Gastrointestinal bleeding | Peptic ulcer | Proton pump inhibitors | Dosage and administration | Drug therapy | Diseases | Drugs | Medical research | Physical examinations | Hospitals | Analgesics | Ulcers | Terminal illnesses | Clinical trials | Pharmaceuticals
Journal Article
Journal of Psychosocial Oncology, ISSN 0734-7332, 07/2019, Volume 37, Issue 4, pp. 494 - 508
Journal Article
Journal Article
The Journal of the American Dental Association (JADA), ISSN 0002-8177, 2012, Volume 143, Issue 11, pp. 1237 - 1247
Journal Article